Study guide

Quality Assessment And Troubleshooting

ASCP MLS Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Orientation To ASCP MLS Certification

Credential Purpose And Role ASCP BOC And Eligibility At A High Level MLS Versus MLS(ASCPi) Wording Application Fee And Transcript Result Basics CAT Exam Model Overview Study Plan From Content Guideline

2 Exam Format, CAT Scoring, And Score details

100 Questions And 2h30m Computer Adaptive Testing One-Best-Answer Multiple Choice Theoretical Versus Procedural Questions Scaled Score 100-999, Minimum 400 Score Notification Timing And Transcript Dependency

3 Blood Banking

Products And Components Blood Group Systems And Immunology Serologic And Molecular Testing Compatibility Testing And Transfusion Practice Physiology And Pathophysiology High-Yield Study Strategy

4 Chemistry

Carbohydrates, Lipids, Proteins, And Nitrogen Compounds Enzymes And Heme Derivatives Acid-Base, Blood Gases, And Electrolytes Endocrinology, Vitamins, And Nutrition Therapeutic Drug Monitoring And Toxicology Calculations And Correlation

5 Hematology And Hemostasis

Normal Hematopoiesis And Cell Morphology Anemia And RBC Disorders Leukocyte Disorders And Disease States Platelet And Coagulation Physiology Hemostasis Testing Smear, Analyzer, And Result Correlation

6 Microbiology

Preanalytic Specimen Handling Bacteriology Analytic Procedures Susceptibility And Organism Identification Logic Mycobacteriology, Virology, Parasitology, And Mycology Postanalytic Reporting Safety And Contamination Awareness

7 Urinalysis And Other Body Fluids

Physical And Chemical Urinalysis Microscopic Sediment Renal Physiology And Disease States CSF And Serous Fluids Body Fluid Cell Counts And Crystals Correlation And Preanalytic Issues

8 Immunology

Principles Of Immune Response Immune-System Diseases Infectious Disease Serology Transplantation And Compatibility Concepts Serologic Procedures And Test Methodology Interpretation Pitfalls

9 Laboratory Operations

Quality Assessment And Troubleshooting Safety Laboratory Mathematics Manual And Automated Methodology Instrumentation And Validation Management And Education Principles

10 Integrated Case Reasoning And Calculations

Correlating Patient Results To Disease States Applying Knowledge To New Facts Calculations And Units Procedural Decision-Making QA/QC In Case Questions Avoiding Memorization-Only Study

11 Practice Strategy And Remediation

Content Percentage Allocation CAT-Aware Practice Mindset Reviewing Misses By Domain Using The Official Guideline Before Third-Party Materials Transcript And Result Timing In Planning Final Remediation Cycles

12 Final Review And Exam-Day Readiness

Final-Week Schedule Timing And Pacing Score Expectations Result And Credential Next Steps Digital Badge And Documentation Post-Exam Actions Without Promises

Quality Assessment And Troubleshooting

Key Takeaways Explain This Topic AI

The six Westgard multirules (1-2s warning, 1-3s, 2-2s, R-4s, 4-1s, 10x) detect random vs systematic error on a Levey-Jennings chart.

A 1-3s or R-4s violation signals random error; 2-2s, 4-1s, and 10x signal systematic shift or trend.

A shift (sudden offset of consecutive points) suggests a new reagent or recalibration; a trend (gradual drift) suggests deteriorating reagent, electrode, or light source.

Quality assessment spans the total testing process: preanalytical (specimen), analytical (QC), and postanalytical (reporting, critical values).

Last updated: June 2026

Statistical Quality Control And Westgard Rules

Quality control (QC) confirms that a method performs within established limits before patient results are released. Each new QC lot is assayed ~20 times to establish a mean and standard deviation (SD) , then plotted daily on a Levey-Jennings chart with lines at the mean and ±1SD, ±2SD, and ±3SD. Roughly 95.5% of in-control points fall within ±2SD and 99.7% within ±3SD, so points outside ±2SD are statistically unusual.

The Westgard multirules convert those limits into reject/accept decisions. Memorize which rule flags random error versus systematic error , because the troubleshooting answer depends on the error type.

  • Rule Trigger Error type Action
  • 1-2s one control >±2SD warning only inspect, do not reject
  • 1-3s one control >±3SD random reject run
  • 2-2s two consecutive >±2SD same side systematic reject run
  • R-4s range between two levels >4SD random reject run
  • 4-1s four consecutive >±1SD same side systematic reject run
  • 10x ten consecutive same side of mean systematic reject run

A classic trap: 1-2s alone is a warning, not a rejection. If a stem shows a single Level 1 control at +2.4SD and asks the next step, the best answer is to evaluate the other rules, not to discard the run.

Shifts, Trends, And Root-Cause Troubleshooting

Patterns over time point to the cause:

A shift is an abrupt move of consecutive points to one side of the mean (often a 10x or 2-2s violation). Likely causes: a new reagent lot , fresh calibration, new control lot, or a new technologist/instrument component.

A trend is a gradual, progressive drift across many points. Likely causes: deteriorating reagent , an aging ion-selective electrode, a failing photometer lamp, or evaporation of control material.

Random scatter with a sudden out-of-range single point (1-3s, R-4s) suggests bubbles, a clot, a pipetting error, or electrical noise.

Worked example: a glucose analyzer's QC was centered for two weeks, then both control levels jumped +2.5SD the morning after a reagent change and stayed there for six days. This abrupt, sustained offset is a shift caused by the new reagent lot , not a calibration drift—recalibrate against the new lot. By contrast, controls creeping upward 0.3SD per day over two weeks describe a trend consistent with reagent deterioration.

Quality assessment is broader than analytical QC. It covers the total testing process in three phases:

Preanalytical — patient prep, correct tube/additive, no hemolysis, correct order of draw, timely transport. Most laboratory errors occur here.

Analytical — QC, calibration, linearity, calibration verification.

Postanalytical — result verification, delta checks, critical (panic) value notification, and correct LIS reporting.

A delta check flags a result that differs implausibly from the patient's prior value (e.g., a hematocrit that jumps from 28% to 45% in hours), prompting a check for a mislabeled or switched specimen before reporting.

Choosing A QC Strategy And Reacting To Failures

Not every analyte needs the full six-rule set. Westgard recommends matching QC stringency to method performance: a high-sigma method (large allowable total error relative to its imprecision) can run a single, lenient rule such as 1-3s with minimal false rejections, while a low-sigma method needs the full multirule scheme with more control levels to catch error reliably. The exam may frame this as balancing error detection against the false-rejection rate — using only 1-2s rejects ~5% of good runs, wasting reagent and time, which is why 1-2s is demoted to a warning.

When a run is rejected, follow an ordered troubleshooting path rather than guessing:

Repeat the control once — a true random error (bubble, clot, mispipette) often does not recur.

If it recurs, open fresh control to rule out deteriorated or improperly stored QC material.

Check reagent (expiration, lot, on-board stability) and recalibrate if a shift coincided with a new lot.

Inspect the instrument — lamp energy, probe/aspiration, temperature, fluidics for carryover.

Do not report patient results generated during an out-of-control run; once resolved, repeat patient samples run since the last acceptable QC.

Patient-Based Indicators And Documentation

Beyond control material, laboratories monitor quality with patient data:

Delta checks compare a patient's current and previous result; a large unexplained change suggests a specimen mix-up or analytical error.

Moving averages (e.g., Bull's algorithm) track the running mean of red-cell indices (MCV, MCH, MCHC) because indices stay stable across a population; a drift signals calibration loss.

Critical value policies require immediate notification with read-back and logging of the caregiver, time, and result.

Absurd-value and limit checks catch transcription or interface errors (e.g., a potassium of 25 mmol/L).

  • Quality tool What it catches
  • Levey-Jennings + Westgard analytical shift/trend/imprecision
  • Delta check specimen mix-up, sudden change
  • Moving average (Bull's) drift in hematology calibration
  • Critical-value log postanalytical reporting failures
  • Proficiency testing accuracy vs peers/reference

Worked example: a CBC shows MCHC of 39 g/dL (well above the usual 32–36 ceiling). Rather than reporting it, recognize that an impossibly high MCHC is a classic flag for a preanalytical interference — lipemia, cold agglutinins, hemolysis, or a clotted/lipemic specimen — warranting smear review and specimen inspection. Documenting every out-of-control event, its root cause, and the corrective action closes the quality loop and is itself an inspectable requirement under accreditation.